Sever Aplastic Anaemia

Recruiting

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

NCT07010237

Conditions

Elderly (People Aged 65 or More), Immunosuppressive Treatment, Sever Aplastic Anaemia

Locations

• Red Blood Cell Diseases Center — Tianjin, Tianjin Municipality, China

View Trial Details

Completed

A Bioequivalence Study of Hetrombopag in Healthy Subjects

NCT05088655

Conditions

Sever Aplastic Anaemia

Locations

• The People's Hospital Of Liaoning Province — Shenyang, Liaoning, China

View Trial Details

Completed

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

NCT05088642

Conditions

Sever Aplastic Anaemia

Locations

• The First Bethune Hospital of Jilin University — Changchun, Jilin, China

View Trial Details

Completed

A Trial of Hetrombopag in Healthy Subjects

NCT05088174

Conditions

Sever Aplastic Anaemia

Locations

• West China Second University Hospital Ethics Committee — Chengdu, Sichuan, China

View Trial Details